IRIS
DEIANA, Giovanni Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.955
AS - Asia 2.873
EU - Europa 2.210
SA - Sud America 1.613
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 80
OC - Oceania 10
Totale 12.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.813
BR - Brasile 1.428
SG - Singapore 1.145
CN - Cina 941
UA - Ucraina 599
FR - Francia 382
SE - Svezia 299
IT - Italia 292
DE - Germania 264
HK - Hong Kong 246
VN - Vietnam 209
FI - Finlandia 104
GB - Regno Unito 91
AR - Argentina 63
TR - Turchia 50
CA - Canada 46
IN - India 43
MX - Messico 35
IQ - Iraq 34
RU - Federazione Russa 34
VE - Venezuela 32
BD - Bangladesh 31
ZA - Sudafrica 31
EC - Ecuador 25
UZ - Uzbekistan 24
BE - Belgio 22
PL - Polonia 21
JP - Giappone 19
CO - Colombia 18
ES - Italia 18
NL - Olanda 18
ID - Indonesia 17
KR - Corea 16
MA - Marocco 16
CL - Cile 15
AE - Emirati Arabi Uniti 12
LT - Lituania 12
PK - Pakistan 12
PY - Paraguay 11
AT - Austria 10
NP - Nepal 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JO - Giordania 9
PE - Perù 9
HN - Honduras 8
UY - Uruguay 8
AU - Australia 7
GT - Guatemala 7
TN - Tunisia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
IR - Iran 6
KE - Kenya 6
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
PR - Porto Rico 5
RO - Romania 5
BO - Bolivia 4
EU - Europa 4
GR - Grecia 4
PA - Panama 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AL - Albania 3
BW - Botswana 3
CI - Costa d'Avorio 3
GA - Gabon 3
HR - Croazia 3
JM - Giamaica 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
IE - Irlanda 2
MD - Moldavia 2
ME - Montenegro 2
QA - Qatar 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
Totale 12.740
Salva come PNG Salva come JPEG
Città #
Dallas 1.633
Singapore 566
Chandler 537
San Jose 380
Jacksonville 374
Ashburn 331
Hong Kong 244
Beijing 195
Princeton 185
Council Bluffs 179
Dearborn 162
Nanjing 152
Santa Clara 137
São Paulo 116
Columbus 107
Wilmington 97
Ho Chi Minh City 87
Lauterbourg 87
New York 86
Nanchang 69
Shanghai 63
Los Angeles 62
Ann Arbor 60
Boardman 60
Milan 55
Tianjin 42
Hebei 40
Hanoi 39
Shenyang 38
Woodbridge 36
Rome 35
Changsha 33
Rio de Janeiro 33
Belo Horizonte 32
Brasília 27
Denver 26
Jiaxing 26
Porto Alegre 25
Sassari 25
Brussels 22
Baghdad 21
Buffalo 21
Campinas 21
Johannesburg 21
Tashkent 21
Curitiba 20
Munich 19
Phoenix 19
Warsaw 19
Jinan 18
Miano 17
Tokyo 17
Seoul 16
Bochum 15
Andover 14
Brooklyn 14
Hangzhou 14
Orem 14
Da Nang 13
London 13
Ribeirão Preto 13
Salvador 13
Atlanta 12
Dhaka 12
Goiânia 12
Helsinki 12
Mexico City 12
San Francisco 12
Carrboro 11
Caxias do Sul 11
Guangzhou 11
Houston 11
Izmir 11
Kunming 11
Montreal 11
Zhengzhou 11
Guarulhos 10
Istanbul 10
Toronto 10
Chennai 9
Duque de Caxias 9
Frankfurt am Main 9
Guayaquil 9
Ipatinga 9
Norwalk 9
Sorocaba 9
Volta Redonda 9
Amman 8
Amsterdam 8
Bauru 8
Campo Grande 8
Canoas 8
Caracas 8
Carapicuíba 8
Chicago 8
Dubai 8
Florianópolis 8
Fortaleza 8
Itajaí 8
Manchester 8
Totale 7.242
Salva come PNG Salva come JPEG
Nome #
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 299
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 220
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 216
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 209
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 207
Herv-k modulates the immune response in als patients 197
Acute hyponatremia and neuroleptic malignant syndrome 194
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 190
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 187
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 181
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 178
Carbamazepine therapy for steroid psychosis 178
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 176
Expressive aphasia exacerbated by lamotrigine and gabapentin 174
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 166
Carbamazepine in delayed-onset cerebellar tremor 165
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 162
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 161
Asterixis and mild encephalopathy induced by gabapentin 161
Beneficial effect of fluoxetine in hyperekplexia 160
Reduced intravenous glutathione in the treatment of early Parkinson's disease 159
Brain interstitial fluid collected trhough implanted tissue cages 153
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 152
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 151
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 150
Carbamazepine in delayed-onset cerebellar tremor 147
Brain interstitial fluid collected through implanted tissue cages 145
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 144
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 141
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 141
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 140
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 139
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 135
Delayedonset cerebellar tremors (DOCT): natural history and treatment 134
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 132
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 131
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 131
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 130
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 130
Tache Noire in a Patient with Acute Q Fever 130
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 129
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 127
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 125
Reduced intravenous glutathione in Parkinson's disease 125
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 123
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 122
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 122
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 120
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 119
Encephalopathies related to antiepileptic drugs 119
Urine bikunin as a marker of renal impairment in Fabry's disease 119
Intravenous glutathione in patients with Parkinson's disease 117
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 116
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 116
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 115
Post-ischemic cerebellar tremors and axonal sprouting in humans 114
Epileptogenic activity of thiocolchicoside 114
Siti di tremore "rubrale" 114
Ceruloplasmin and oxidative stress in multiple sclerosis 112
Cerebral and cerebellar diaschisis following carbamazepine therapy 112
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 112
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 111
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 110
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 109
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 109
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 106
Levetiracetam in stiff-person syndrome 106
Cytokines and multiple sclerosis severity: no correlation among Sardinians 106
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 106
Preliminary experience with fluoxetine in primary focal dystonias 104
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 103
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 102
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 101
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 101
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 100
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 99
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 99
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 98
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 98
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 98
Neurological disorders associated with Mycoplasma pneumoniae infection 97
Pharmacology of delayed-onset cerebellar tremors 97
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 97
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 96
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 96
Chronic parkinsonism after use of diquat: clinical and MRI studies 94
Neuroleptic maglignant syndrome and related syndromes in a neurological population 92
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 92
Pharmacology of delayed-onset cerebellar tremors 90
Delayed-onset cerebellar tremor after stroke 89
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 88
Glycosaminoglycans and fabry’s disease 86
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 84
Discinesie bucco-linguali indotte dal fenobarbitale 82
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 79
Familial autoimmune MuSK positive myasthenia gravis 79
Effetti avversi psichiatrici da steroidi e carbamazepina 78
Ceftriaxone has a therapeutic role in Alexander disease 76
Topiramate in patients with cerebellar tremor: a controlled trial 70
Neuroimaging leads to recognition of previously undiagnosed Fabry 53
Totale 12.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022346 0 0 0 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/20252.834 71 13 177 55 145 68 210 531 1.020 355 104 85
2025/20264.252 175 1.071 772 593 335 243 497 117 187 133 91 38
2026/20271.214 97 292 342 483 0 0 0 0 0 0 0 0
Totale 12.825